Slide 1Pandemic influenza A (2009) Clinical Controversies in Clinical Care: What worked and what did not David SC Hui MBBS, MD(UNSW), FRACP, FRCP, FCCP, FHKCP, FHKAM Professor,…

1. ECDC expert opinion on the efficacy, effectiveness and safety of influenza neuraminidase inhibitors Pasi Penttinen Head of influenza and other respiratory viruses DP (acting)…

Slide 1 Slide 2 WHO Draft Rapid Response + Containment, May 2006 Slide 3 Projected Outbreak of H5N1 in Thailand Red = new cases. Green = areas where the epidemic has finished.…

Slide 1 ANTIVIRALS and IMMUNOTHERAPIES in PANDEMIC INFLUENZA IOM Briefing April 4, 2005 Frederick G. Hayden, M.D. Division of Infectious Diseases and International Health…

Slide 1 Treatment of Influenza in Adults Andrew T. Pavia M.D. George and Esther Gross Professor and Chief Pediatric Infectious Diseases University of Utah Slide 2 Treatment…

Slide 1 Epidemic and Pandemic Use of Antivirals Introduction 15 September 2008 Frederick G. Hayden, M.D. University of Virginia Health System Charlottesville, Virginia, USA…

Establishing a surveillance programme for measurement of Neuraminidase Inhibitor susceptibility Maria Zambon Oct 2006 G224 Practicalities Source of isolates Viral subtype…

Sheila Negrini Parmezan São Paulo, 2011 Introduction The neuraminidase inhibitors (NAIs), oseltamivir and zanamivir, are currently the antiviral drugs of choice Potent…

Establishing a surveillance programme for measurement of Neuraminidase Inhibitor susceptibility Maria Zambon Oct 2006 G224 Practicalities Source of isolates Viral subtype…